1. Home
  2. BNTC vs PNNT Comparison

BNTC vs PNNT Comparison

Compare BNTC & PNNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$10.91

Market Cap

411.4M

Sector

Health Care

ML Signal

HOLD

Logo PennantPark Investment Corporation

PNNT

PennantPark Investment Corporation

HOLD

Current Price

$4.53

Market Cap

397.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNTC
PNNT
Founded
1995
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
411.4M
397.7M
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
BNTC
PNNT
Price
$10.91
$4.53
Analyst Decision
Strong Buy
Hold
Analyst Count
3
5
Target Price
$27.67
$5.85
AVG Volume (30 Days)
161.7K
728.5K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
21.29%
EPS Growth
80.94
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$13.14
Revenue Growth
N/A
N/A
52 Week Low
$9.85
$4.51
52 Week High
$17.15
$7.53

Technical Indicators

Market Signals
Indicator
BNTC
PNNT
Relative Strength Index (RSI) 42.12 33.17
Support Level $10.10 N/A
Resistance Level $12.91 $4.93
Average True Range (ATR) 0.71 0.15
MACD -0.10 0.00
Stochastic Oscillator 9.33 3.33

Price Performance

Historical Comparison
BNTC
PNNT

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

Share on Social Networks: